Classifica tra le azioni
#2836
CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops... CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States. The company’s product candidate is cretostimogene, an investigational oncolytic immunotherapy, which is in phase 2 clinical trials of cretostimogene in patients with high-risk NMIBC after BCG failure; a phase 3 clinical trials to evaluate the safety and efficacy of cretostimogene as monotherapy in the treatment of patients who have received adequate BCG therapy with high-risk BCG-unresponsive, CIS-containing NMIBC and BCG-unresponsive Ta, or T1 papillary tumors; phase 3 BOND-003 Cohort C trials as a single agent; phase 3 BOND-003 Cohort P as a single agent in patients with BCG-UR papillary-only NMIBC. It also develops cretostimogene monotherapy for intermediate-risk NMIBC following TURBT, which is in phase 3 PIVOT-006 clinical trials to assess the safety and efficacy of adjuvant cretostimogene; and cretostimogene monotherapy for high-risk NMIBC in phase 2 CORE-008 clinical trials to assess the safety and clinical outcomes of cretostimogene in treating patients with high-risk NMIBC, including BCG-exposed and BCG-naïve NMIBC. The company was formerly known as Cold Genesys, Inc. and changed its name to CG Oncology, Inc. in June 2020. CG Oncology, Inc. was founded in 2010 and is headquartered in Irvine, California.
Prezzo delle azioni
$78.86
Capitalizzazione di mercato
$6.96B
Variazione (1 giorno)
0.80%
Variazione (1 anno)
210.23%
Scambia CG Oncology Inc. (CGON)
Il prezzo CGON con la capitalizzazione del mercato della B
Capitalizzazione di mercato di CG Oncology Inc.(CGON)
Capitalizzazione di mercato: $6.96B
A partire dal August 2026, CG Oncology Inc. ha una capitalizzazione di mercato pari a $6.96B. Questo rende CG Oncology Inc. la 2836th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di CG Oncology Inc. dal 2024 al 2026
CGON in paragone con la classifica dei più popolari stocks
| Il prezzo per CGON |
|
Attivo B |
Capitalizzazione del mercato a B |
Risultati |
|
|
|
|
$5.152T
|
+73,976.74%
|
|
|
|
|
$4.537T
|
+65,128.25%
|
|
|
|
|
$4.169T
|
+59,831.04%
|
|
|
|
|
$3.642T
|
+52,265.67%
|
|
|
|
|
$2.805T
|
+40,222.92%
|
